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Abstract 
 
Breast cancer is the most common malignancy in women. There is a high degree of heterogeneity 
in breast tumours and they can be divided into subtypes that have different expression pattern and 
clinical outcome. Ductal Carcinoma in situ (DCIS) is regarded as a precursor of invasive ductal 
breast cancer. Some DCIS lesions will not change in many years, while other will rapidly progress 
into invasive cancer. It is therefore important to be able to distinguish clinical subgroups of DCIS 
with a high risk of progression to invasive disease.  
 
Aim: Psoriasin is one of the most abundant transcripts in high-grade DCIS with higher risk of local 
recurrence. Psoriasin has been associated with poor clinical outcome, suggesting its potential 
involvement in tumour progression. To date, several functions of psoriasin have been proposed, but 
none of these can fully explain its involvement in breast tumour progression. The aim of this thesis 
was to elucidate the functional relevance of psoriasin for the initiation and progression of DCIS, and 
to gain insight into regulatory pathways that control the expression.  
 
Results: High-grade DCIS is characterised by a high apoptotic rate and reactive oxidant species 
(ROS) are known to influence this process. We report the induction of psoriasin by ROS in normal 
mammary epithelial cells. This induction was repressed by the anti-apoptotic protein Bcl-2 and the 
antioxidant NAC. Normal mammary epithelial cells with a stable retroviral overexpression of 
psoriasin were significantly more resistant to ROS-induced cell death. Furthermore, we 
demonstrate that the NF-κB pathway is potentially involved in the induction of psoriasin expression. 
(Paper I) 
 
IFNγ has been shown to exert anti-tumour action in breast cancer. We report the downregulation of 
psoriasin by IFNγ in a breast cancer cell line and the downregulation of psoriasin induced by 
culturing mammary epithelial cells in suspension (loss of contact to extracellular matrix). This effect 
was shown to be mediated by the activation of the STAT1 signalling pathway. In a mouse 
mammary epithelial cell line with tetracycline-induced psoriasin expression, we observed the 
increased viability of psoriasin-expressing cells after IFNγ treatment. (Paper II) 
 
The massive induction of psoriasin in suspension culture compared to other stimuli (starvation, 
confluence and ROS) suggests that changes in adhesion to the extracellular matrix may contribute 
to the expression of psoriasin. We showed that the downregulation of intercellular adhesion 
molecule 1 (ICAM-1) (by short hairpin RNA) in mammary epithelial cells increased the expression of 
psoriasin, through the phospholipase C (PLC)-IP3 pathway, as well as the oncogenic protein 
mucin1 (MUC1). (Paper III)   
 
The interaction between breast epithelial cells and the extracellular matrix contribute to pathological 
processes and to the normal development of a differentiated structure. Psoriasin has previously 
been related to epithelial cell differentiation in the skin. We now report that mammary epithelial cells 
shifted from a CD44+/CD24- to a CD44-/CD24+ phenotype (representing differentiated luminal 
epithelia) when cultured in confluent and suspension conditions. Interestingly, this result was not 
observed when psoriasin was suppressed using short hairpin RNA. (Paper IV)  
 
Conclusions: We have shown data suggesting that the high expression of psoriasin in high-grade 
DCIS tumours may be dependent on the production of ROS and a change in adhesion to the ECM, 
involving ICAM-1 and MUC1. The psoriasin expression leads to increased survival of the breast 
epithelial cells. Our data also reveal that psoriasin is tightly linked to the expression of CD24. 
Therefore, it is likely that psoriasin play a role in the differentiation of mammary epithelial cells. 
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